Skip to main content
Log in

Ileal Crohn’s disease: CEUS determination of activity

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Transabdominal ultrasound is currently accepted as a clinical first-line tool in the assessment of Crohn’s disease activity. During recent years, great improvements have been achieved in ultrasound examination with the introduction of high-frequency transducers, ultrasonographic microbubble contrast agents, and dedicated contrast-specific ultrasound software. Therefore, contrast-enhanced ultrasonography (CEUS) is emerging as one of the most important imaging techniques in the diagnosis and follow-up of patients with ileal Crohn’s disease. It is non-invasive and non-ionizing, easily repeatable, well-tolerated by patients and has significant diagnostic accuracy. Moreover, the possibility to monitor response to therapies, describing, and quantifying contrast enhancement behavior by specific software, represents an interesting aspect of its utilization, considering the still open questions about the correct use of immunosuppressive and biological agents. The aim of our review is to provide an updated overview of the role of CEUS in the patients who have an ileal localization of Crohn’s disease, defining its qualitative and quantitative features.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Stange EF, Travis SPL, Vermeire S, et al. (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 55(Supplement 1):i1–i15. doi:10.1136/gut.2005.081950a

    Google Scholar 

  2. Satsangi J, Silverberg MS, Vermeire S, et al. (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55(6):749–753

    Article  PubMed  CAS  Google Scholar 

  3. Schnitzler F, Fidder H, Ferrante M, et al. (2009) Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn’s disease. Inflamm Bowel Dis 15(9):1295–1301

    Article  PubMed  Google Scholar 

  4. Baert F, Moortgat L, Van Assche G, et al. (2010) Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease. Gastroenterology 138:463–468

    Article  PubMed  Google Scholar 

  5. Huprik JE, Fletcher JG (2009) CT enterography: principles, technique and utility in Crohn’s disease. Eur J Radiol 69(3):393–397

    Article  Google Scholar 

  6. Siddiki H, Fidler J (2009) MR imaging of the small bowel in Crohn’s disease. Eur J Radiol 69(3):409–417

    Article  PubMed  Google Scholar 

  7. Van Assche G, Dignass A, Panes J, et al. (2010) The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. J Crohns Colitis 4:7–27

    Article  PubMed  Google Scholar 

  8. Quaia E (2007) Microbubble ultrasound contrast agents: an update. Eur Radiol 17(8):1995–2008

    Article  PubMed  Google Scholar 

  9. Wilson SR, Burns PN (2010) Microbubble-enhanced US in body imaging: what role? Radiology 257(1):24–39

    Article  PubMed  Google Scholar 

  10. Piscaglia F, Bolondi L (2006) Italian Society for Ultrasound in Medicine, Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32(9):1369–1375

    Article  PubMed  Google Scholar 

  11. Torzilli G (2005) Adverse effects associated with SonoVue use. Expert Opin Drug Saf 4(3):399–401

    Article  PubMed  CAS  Google Scholar 

  12. Geleijnse ML, Nemes A, Vletter WB, et al. (2009) Adverse reactions after the use of sulphur hexafluoride (SonoVue) echo contrast agent. J Cardiovasc Med 10(1):75–77

    Article  Google Scholar 

  13. Maconi G, Parente F, Bollani S, et al. (1996) Abdominal ultrasound in the assessment of extent and activity of Crohn’s disease: clinical significance and implication of bowel wall thickening. Am J Gastroenterol 91(8):1604–1609

    PubMed  CAS  Google Scholar 

  14. Fraquelli M, Colli A, Casazza G, et al. (2005) Role of US in detection of Crohn disease: meta-analysis. Radiology 236(1):95–101

    Article  PubMed  Google Scholar 

  15. Migaleddu V, Scanu AM, Quaia E, et al. (2009) Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn’s disease. Gastroenterology 137(1):43–52

    Article  PubMed  Google Scholar 

  16. Castiglione F, de Sio I, Cozzolino A, et al. (2004) Bowel wall thickness at abdominal ultrasound and the one-year-risk of surgery in patients with Crohn’s disease. Am J Gastroenterol 99(10):1977–1983

    Article  PubMed  Google Scholar 

  17. Rigazio C, Ercole E, Laudi C, et al. (2009) Abdominal bowel ultrasound can predict the risk of surgery in Crohn’s disease: proposal of an ultrasonographic score. Scand J Gastroenterol 44(5):585–593

    Article  PubMed  Google Scholar 

  18. Rispo A, Bucci L, Pesce G, et al. (2006) Bowel sonography for the diagnosis and grading of postsurgical recurrence of Crohn’s disease. Inflamm Bowel Dis 12(6):486–490

    Article  PubMed  Google Scholar 

  19. Zalis M, Singh AK (2004) Imaging of inflammatory bowel disease: CT and MR. Scand J Gastroenterol 43(6):719–726

    Google Scholar 

  20. Nylund K, Leh S, Immervoll H, et al. (2008) Crohn’s disease: comparison of in vitro ultrasonographic images and histology. Scand J Gastroenterol 43:719–726

    Article  PubMed  Google Scholar 

  21. Maconi G, Carsana L, Fociani P, et al. (2003) Small bowel stenosis in Crohn’s disease: clinical, biochemical and ultrasonographic evaluation of histological features. Aliment Pharmacol Ther 18(7):749–756

    Article  PubMed  CAS  Google Scholar 

  22. Migaleddu V, Quaia E, Scano D, et al. (2008) Inflammatory activity in Crohn disease: ultrasound findings. Abdom Imaging 33(5):589–597

    Article  PubMed  Google Scholar 

  23. Maconi G, Sampietro GM, Parente F, et al. (2003) Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn’s disease: a prospective comparative study. Am J Gastroenterol 98(7):1545–1555

    Article  PubMed  Google Scholar 

  24. Gasche C, Moser G, Turetschek K, et al. (1999) Transabdominal bowel sonography for the detection of intestinal complications in Crohn’s disease. Gut 44(1):112–117

    Article  PubMed  CAS  Google Scholar 

  25. Spalinger J, Patriquin H, Miron MC, et al. (2000) Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 217(3):787–791

    PubMed  CAS  Google Scholar 

  26. Esteban JM, Maldonado L, Sanchiz V, et al. (2001) Activity of Crohn’s disease assessed by colour Doppler ultrasound analysis of the affected loops. Eur Radiol 11:1423–1428

    Article  PubMed  CAS  Google Scholar 

  27. Drews BH, Barth TF, Hänle MM, et al. (2009) Comparison of sonographically measured bowel wall vascularity, histology, and disease activity in Crohn’s disease. Eur Radiol 19(6):1379–1386

    Article  PubMed  CAS  Google Scholar 

  28. Yekeler E, Danalioglu A, Movasseghi B, et al. (2005) Crohn disease activity evaluated by Doppler ultrasonography of the superior mesenteric artery and the affected small-bowel segments. J Ultrasound Med 24(1):59–65

    PubMed  Google Scholar 

  29. Ludwig D, Wiener S, Brüning A, et al. (1999) Mesenteric blood flow is related to disease activity and risk of relapse in Crohn’s disease: a prospective follow-up study. Am J Gastroenterol 94(10):2942–2950

    Article  PubMed  CAS  Google Scholar 

  30. Byrne MF, Farrell MA, Abass S, et al. (2001) Assessment of Crohn’s disease activity by Doppler sonography of the superior mesenteric artery, clinical evaluation and the Crohn’s disease activity index: a prospective study. Clin Radiol 56(12):973–978

    Article  PubMed  CAS  Google Scholar 

  31. Di Sabatino A, Fulle I, Ciccocioppo R, et al. (2002) Doppler enhancement after intravenous levovist injection in Crohn’s disease. Inflamm Bowel Dis 8(4):251–257

    Article  PubMed  Google Scholar 

  32. Rapaccini GL, Pompili M, Orefice R, et al. (2004) Contrast-enhanced power Doppler of the intestinal wall in the evaluation of patients with Crohn disease. Scand J Gastroenterol 39(2):188–194

    Article  PubMed  CAS  Google Scholar 

  33. Robotti D, Cammarota T, Debani P, et al. (2004) Activity of Crohn disease: value of Color-Power-Doppler and contrast-enhanced ultrasonography. Abdom Imaging 29(6):648–652

    Article  PubMed  CAS  Google Scholar 

  34. Serra C, Menozzi G, Labate AM, et al. (2007) Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn’s disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol 62(1):114–121

    Article  PubMed  Google Scholar 

  35. Parente F, Maconi G, Bollani S, et al. (2002) Bowel ultrasound in assessment of Crohn’s disease and detection of related small bowel strictures: a prospective comparative study versus x ray and intraoperative findings. Gut 50(4):490–495

    Article  PubMed  CAS  Google Scholar 

  36. Limberg B (1999) Diagnosis of chronic inflammatory bowel disease by ultrasonography. Z Gastroenterol 37(6):495–508

    PubMed  CAS  Google Scholar 

  37. Kratzer W, Schmidt SA, Mittrach C, et al. (2005) Contrast-enhanced wideband harmonic imaging ultrasound (SonoVue): a new technique for quantifying bowel wall vascularity in Crohn’s disease. Scand J Gastroenterol 40(8):985–991

    Article  PubMed  Google Scholar 

  38. Guidi L, De Franco A, De Vitis I, et al. (2006) Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn’s disease. Eur Rev Med Pharmacol Sci 10(1):23–26

    PubMed  CAS  Google Scholar 

  39. De Franco A, Di Veronica A, Bock E, et al. (2011) Ileal Crohn’s Disease: mural microvascularity quantified by contrast-enhanced ultrasound correlates with disease activity. Radiology (Accepted)

  40. Schreyer AG, Finkenzeller T, Gössmann H, et al. (2008) Microcirculation and perfusion with contrast enhanced ultrasound (CEUS) in Crohn’s disease: first results with linear contrast harmonic imaging (CHI). Clin Hemorheol Microcirc 40(2):143–155

    PubMed  CAS  Google Scholar 

  41. Girlich C, Jung EM, Iesalnieks I, et al. (2009) Quantitative assessment of bowel wall vascularisation in Crohn’s disease with contrast-enhanced ultrasound and perfusion analysis. Clin Hemorheol Microcirc 43(1):141–148

    PubMed  CAS  Google Scholar 

  42. Girlich C, Jung EM, Huber E, et al. (2011) Comparison between preoperative quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and operative macroscopic findings and results of histopathological scoring in Crohn’s disease. Ultraschall Med 32(2):154–159

    Article  PubMed  CAS  Google Scholar 

  43. Quaia E, Migaleddu V, Baratella E, et al. (2009) The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled microbubble injection in patients with Crohn’s disease Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment. Eur J Radiol 69(3):438–444

    Article  PubMed  Google Scholar 

  44. Schirin-Sokhan R, Winograd R, Tischendorf S, et al. (2011) Assessment of inflammatory and fibrotic stenoses in patients with Crohn’s disease using contrast-enhanced ultrasound and computerized algorithm: a pilot study. Digestion 83(4):263–268

    Article  PubMed  Google Scholar 

  45. Ripollés T, Martínez MJ, Paredes JM, et al. (2009) Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 253(1):241–248

    Article  PubMed  Google Scholar 

  46. Kumar P, Domjan J, Bhandari P, et al. (2009) Is there an association between intestinal perfusion and Crohn’s disease activity? A feasibility study using contrast-enhanced ultrasound. Br J Radiol 82(974):112–117

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio De Franco.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Franco, A., Marzo, M., Felice, C. et al. Ileal Crohn’s disease: CEUS determination of activity. Abdom Imaging 37, 359–368 (2012). https://doi.org/10.1007/s00261-011-9831-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-011-9831-9

Keywords

Navigation